Altered Pharmacokinetics of Ceftazidime in Critically Ill Patients
Many critically ill patients have increased extracellular fluid which might affect ceftazidime pharmacokinetics. We investigated the pharmacokinetics of ceftazidime in 15 adult intensive care patients receiving 2 g of ceftazidime intravenously three times a day. The ceftazidime mean (standard deviat...
Tallennettuna:
| Julkaisussa: | Antimicrob Agents Chemother |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Microbiology (ASM)
1999
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89369/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10390248/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.7.1798 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|